Last reviewed · How we verify
NCT05246449: VitalCare
Evaluate the Benefit of an Individualised Treatment Plan (VitalCare) VS SOC in OSA Patients Treated With CPAP/APAP
NA trial testing individualised treatment plan (VitalCare) and associated remote medical monitoring in Obstructive Sleep Apnoea Syndrome (OSAS) in 113 participants. Completed in 30 June 2024.
15 February 2023
Quick facts
| Lead sponsor | Air Liquide Santé International |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 113 |
| Start date | 15 February 2022 |
| Primary completion | 15 February 2023 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- individualised treatment plan (VitalCare) and associated remote medical monitoring
Conditions studied
- Obstructive Sleep Apnoea Syndrome (OSAS) — all drugs for Obstructive Sleep Apnoea Syndrome (OSAS) →
Sponsor
Air Liquide Santé International — full company profile →
Who can join
18 and older, any sex, with Obstructive Sleep Apnoea Syndrome (OSAS). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
According to a stratification procedure, the objective of a personalised care plan (VitalCare) is to identify points for improvement since the early stage of the patient's pathway of CPAP/APAP treatment and to adjust patient follow-up .
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05246449
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Air Liquide Santé International trials
Trials by the same sponsor.
- NCT05793645 — Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program · NA · unknown
- NCT04635280 — Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Close · NA · completed
- NCT04615078 — Study Evaluating Telemonitoring and Experimentation in Telemedicine for the Improvement of Healthcare Pathways (ETAPES P · NA · completed
- NCT04233229 — Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled Type 2 · NA · completed
- NCT03436212 — Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05246449 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Air Liquide Santé International
- Last refreshed: 10 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05246449.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing